Rodney Perkins M.D. – Chairman, Sound ID
Dr. Perkins brings an important clinical perspective to Sound ID, guiding the company’s innovations in technologies that optimize audio devices to meet individuals’ listening experience and compensate for the interference of background noise.  Dr. Perkins is recognized among the top ear specialists in the world, having founded the California Ear Institute at Stanford and served as a professor of surgery at Stanford University School of Medicine.

Dr. Perkins is an otologist and the founder of Sound ID and former chairman of three public companies: ReSound Corporation, Laserscope and Collagen Corporation. He is the founder and chairman of Novacept, Pulmonix and Cohesion. His vision and leadership has been instrumental in the success of these and other Bay Area-based technology companies.

Dr. Perkins holds eight issued patents and received his medical degree fromIndiana University.

Rick Darnaby – President & Chief Executive Officer, Sound ID
Rick Darnaby joined Sound ID in April of 2005 as President and Chief Executive Officer. Mr. Darnaby brings a wealth of global executive level experience and success from Motorola, NutraSweet, Monsanto, and Somera Communications, Inc. He has a track record of running efficient, agile, entrepreneurial, operating companies within these large corporations.  His strong strategic and financial focus, operational skills, and leadership capacity, are tremendous assets as Sound ID aggressively builds a new category in the global medical device and consumer electronics markets.

Mr. Darnaby has built a number of large global businesses in a variety of industries. His global business experience is extensive and includes Region President and General Manager for the Motorola Company in EMEA (Europe, Middle East and Africa). He also served as the Senior Vice President and General Manager of the Global Consumer Solutions Groups, which included the consumer products businesses. Following Motorola, Mr. Darnaby served as President and CEO of Somera Communications, Inc., a global provider of telecom and IP infrastructure equipment and services traded on NASDAQ. He is the former President of The NutraSweet Group, a subsidiary of Monsanto, and also CEO of Monsanto, Canada.  Mr. Darnaby has served on a number of corporate boards of directors, as well as a number of government and academic boards and committees in the United States and abroad. He has been a guest lecturer at top graduate business schools, including Harvard and Northwestern’s Kellogg school.

Mr. Darnaby holds a B.S. and an M.B.A. from Oklahoma State University, and an Advanced Management Degree from the I.N.S.E.A.D. (Institute of European Administration) in Fountainbleau, France.

Annette Campbell-White – Managing Partner, MedVenture Associates
A native ofNew Zealand, Ms. Campbell-White began her career in strategic planning for the Medishield Division of British Oxygen Co., Inc., in London, England. Her rich and varied background includes management consulting in the biomedical area with SRI International and ownership of a successful biomedical consulting firm.

Ms. Campbell-White earned her reputation for thorough research and steady focus at Hambrecht & Quist, developing the Health Care business and rising to the position of General Partner in 1981, the first woman to do so in Hambrecht & Quist's history. She also founded the Hambrecht & Quist Health Care Conference, which remains the most important and prestigious gathering of its kind. Later, she was a Special Limited Partner of L.F. Rothschild, Unterberg, Towbin, working in corporate finance and venture capital in the life sciences area.

Ms. Campbell-White went on to found MedVenture Associates (MVA) in 1986. Though MVA has been her principal interest, she previously maintained an active involvement in other funds as well. Campbell-White has served as a General Partner of Paragon Venture Partners II, L.P. She was also a Venture Partner of USVP, and a Special Limited Partner of InterWest Partners IV from 1990 to 1992.

Prior to her involvement with MVA, noteworthy investments included Home Health Care of America (later Caremark); Diasonics, Inc.; Xoma Corp., and LifeScan, Inc.

Since 1986, selected investments made by Campbell-White have resulted in successful IPOs or acquisitions at a value greater than $100 million, including: Ventritex, Inc.; ReSound Corp.; ArthroCare Corp.; Coulter Pharmaceutical, Inc.; ViCal, Inc.; Glycomed, Inc.; VidaMed Inc.; Cardiac Pathways Corp.; Devices for Vascular Intervention, Inc.; Total Pharmaceutical Care, Inc.; Physiometrix, Inc.; Abaxis, Inc.; AneuRx Corp.; Cardiovascular Imaging Systems, Inc.; HealthCentral.com, Inc., Neoforma.com, PercuSurge Inc., TheraSense, Inc., Spinal Dynamics, Cutera, Inc. and Novacept.

Education
B.Sc., Chemical Engineering
M.S. degree, Physical Chemistry, University of Cape Town, South Africa

Member, Board of Directors, Asthmatx, Inc.
Member, Board of Directors, BeneChill, Inc.
Member, Board of Directors, Calfacior Corporation
Member, Board of Directors, Cutera, Inc. 
Member, Board of Directors, EKOS Corp.
Member, Board of Directors, Neothermia, Inc
Member, Board of Directors, NeuraLieve, Inc.
Member, Board of Directors, PolymorfiX, Inc.
Member, Board of Directors, PolyRemedy, Inc.
Member, Board of Directors, Sound ID
Member, Board of Directors, Vascular Control Systems, Inc.
Member, Board of Trustees, World Affairs Council of Northern California
Board Member, Cal Performances

Richard Kashnow Ph.D. – Former Chairman and CEO, RayChem
Richard A. Kashnow is the retired president of Tyco Ventures, a venture capital unit he established for Tyco International in 1999, following Tyco's acquisition of Raychem Corporation.

For several years before that, Dr. Kashnow served as chairman, chief executive officer, and president of Raychem, a $1.8 billion public technology company specializing in electronic components and engineered materials. Prior to Raychem, Dr. Kashnow held executive positions with Manville Corporation, where he became president of its $1 billion building products and engineered materials subsidiary, Schuller Corporation.

Dr. Kashnow began his business career as a physicist at General Electric's corporate R&D center. During his seventeen years at GE, he held technical and general management positions, including corporate technology consultant, manager of GE Aerospace's electronics laboratory, and general manager of GE Lighting's quartz and chemical products business.

Dr. Kashnow earned a BS degree in physics from Worcester Polytechnic Institute (1963) and a PhD in solid-state physics fromTufts University. He served as an officer in the U.S. Army (1968-1970).

Dr. Kashnow is also a director of ParkerVision (NASDAQ: PRKR), ActivCard (Nasdaq:ACTI) and Komag (Nasdaq:KOMG). He also serves as non-executive chairman of Komag.

Philip Schlein – Former President and CEO, Macy's California

Philip S. Schlein joined USVP in 1985 after a successful 28-year career as an operating executive in the retailing industry. For 11 years prior to joining USVP, Mr. Schlein was President and CEO of Macy's California. Under his leadership, Macy's California sales grew from just under $200 million to almost $1.2 billion; profits grew from $17 million to $108 million. Phil began his retail career with R.H. Macy, Inc. from 1977 to 1984 and served on the Board of Directors of Apple Computer for eight years from 1979 to 1987. Since joining USVP, Mr. Schlein has originated a number of investments in the consumer/retail sector including PETsMart, Fresh Choice and The House of Blues.

In recent years, Mr. Schlein has been active in the Internet and eCommerce areas, served on the Boards of Directors of iVillage, HomeGrocer.com, NBCi, among others. Mr. Schlein currently serves on the Boards of Directors of Catalist, Specialtys, Auction Drop and Oakville Grocery. Phil holds a B.S. in Economics from the University of Pennsylvania.

Pearson Spaght – President, Fletcher Spaght Ventures

Mr. Spaght is President of Fletcher Spraght Ventures,

  • President, Fletcher Spaght, Inc.
  • Vice President, Strategy, Raymark Corporation
  • Manager, TheBoston Consulting Group, Inc.
  • MBA, Stanford University
  • MS, Aero/Astronautical Engineering, Stanford University
  • BS, Mechanical Engineering, Stanford University

Immanuel Thangaraj – Managing Director, Woodlands Health Ventures
Immanuel Thangaraj has over 12 years of experience in operations and venture capital. Mr. Thangaraj began his venture capital career in 1992 as an Associate and CFO at ARCH Venture Partners (AVP), a $750 million venture capital firm targeting early stage technology and healthcare investments. In his initial tenure at AVP, he managed one of its portfolio companies, a medical information company, until its sale to a large hospital supplies company. In 1995, Mr. Thangaraj become CEO of Integrated Telemanagement, a telecommunications company, which he helped to found, until its sale to a public company.

Mr. Thangaraj joined Essex Woodlands in 1997. He currently serves on the Board of Directors of CBR Systems, Acura Pharmaceuticals (formerly Halsey Pharmaceuticals), iKnowMed Systems, Medlogics, and Sound ID. He is also responsible for Essex Woodland’s investments in Accumetrics and Novacept.

Mr. Thangaraj holds a Bachelor of Arts and a Masters in Business Administration from the University of Chicago. it@ewhv.com

Corporate Counsel:
Mario Rosati – Senior Partner, Wilscocn, Sonsini, Goodrich and Rosati
Mario Rosati has been with Wilson Sonsini Goodrich & Rosati since 1971, first as an associate and as a partner since January 1975. Mario specializes in corporate law, especially as it relates to high-technology companies. He is a member of the firm's Executive Management Committee, Policy Committee and is also the managing partner of WS Investments, an investment partnership, composed of the partners and associates of the firm. WS Investments has invested in a number of emerging corporations over the years.

In 1981, Mr. Rosati participated in the Innovation and Entrepreneurship Task Force to the office of the President Elect, Ronald Reagan, and in 1982-83 served as a Special Consultant to the Secretary, Drew Lewis, and Deputy Secretary of Transportation, Darrel Trent. In this connection he was a member of the Airport Access Task Force.

Mr. Rosati is a director of Aehr Test Systems, Sanmina-SCI Corporation, Symyx Technologies, Inc., and Vivus, Inc., all publicly traded companies, as well as several privately-held companies. Mr. Rosati has served as Judge Pro-Tem in the Superior Court, State of California, San Mateo County and currently serves on the Panel of Arbitrators for San Mateo County. He is also on the UC Berkeley Foundation Board of Trustees.

Named in the 2005 edition of Chambers USA: America's Leading Business Lawyers, Mr. Rosati is said to impress "with his ability to form strong client relationships." Also in 2005, he was named a Northern California "Super Lawyer" by Law & Politics and San Francisco Magazine.

Mr. Rosati received his J.D. from Boalt Hall, University of California at Berkeley, in 1971. While attending Boalt, Mario received the Am Jur Award in Corporations. Mario is an adjunct Professor, Haas School of Business, University of California at Berkeley and serves on the Board of Advisors for the Lester Center for Entrepreneurship and Innovation. He did his undergraduate work at the University of California at Los Angeles, where he received a Bachelor in Arts with a major in history in 1968.

© 2006 Sound ID

Terms of Use

Privacy Policy

Contact Us

Home